IP Library › Patent Application 13728855
Patent Application
App. No. 13/728,855

HYALURONIC ACID-COLLAGEN MATRICES FOR TISSUE ENGINEERING

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/728,855
Abstract

Hydrogels comprising a macromolecular matrix including a crosslinked combination of hyaluronic acid and collagen, are provided for tissue engineering applications.

Claims (37)

1 . A hydrogel composition useful for treating a human or veterinary subject having a disorder characterized by tissue damage or loss, the composition comprising:

a hyaluronic acid component; and

a collagen component;

wherein the hyaluronic acid component is crosslinked to the collagen component by an ester bond or an amide bond.

2 . The composition of claim 1 having a weight ratio of the hyaluronic acid component to the collagen component of about 1 to about 7.

3 . The composition of claim 1 having a weight ratio of the hyaluronic acid component to the collagen component of about 2.

4 . The composition of claim 1 having a weight ratio of the hyaluronic acid component to the collagen component of about 3.

5 . The composition of claim 1 having a weight ratio of the hyaluronic acid component to the collagen component of about 4.

6 . The composition of claim 1 having a weight ratio of the hyaluronic acid component to the collagen component of about 6.

7 . The composition of claim 1 having a collagen concentration of at least about 3 mg/ml to about 12 mg/ml.

8 . The composition of claim 7 having a hyaluronic acid concentration of about 3 mg/ml to about 24 mg/ml.

9 . The composition of claim 1 having a collagen concentration of about 3 mg/mL.

10 . The composition of claim 9 having a hyaluronic acid concentration of about 3 mg/mL to about 20 mg/mL.

11 . The composition of claim 9 having a hyaluronic acid concentration of about 3 mg/mL.

12 . The composition of claim 9 having a hyaluronic acid concentration of about 12 mg/mL.

13 . The composition of claim 9 having a hyaluronic acid concentration of about 20 mg/mL.

14 . The composition of claim 1 having a collagen concentration of about 6 mg/mL.

15 . The composition of claim 14 having a hyaluronic acid concentration of about 12 mg/mL.

16 . The composition of claim 1 having a collagen concentration of about 8 mg/mL.

17 . The composition of claim 16 having a hyaluronic acid concentration of about 16 mg/mL.

18 . The composition of claim 1 having a collagen concentration of about 12 mg/mL.

19 . The composition of claim 18 having a hyaluronic acid concentration of about 12 mg/mL to about 24 mg/mL.

20 . The composition of claim 18 having a hyaluronic acid concentration of about 12 mg/mL.

21 . The composition of claim 18 having a hyaluronic acid concentration of about 24 mg/mL.

22 . A method for treating a human or veterinary subject having a disorder characterized by soft tissue damage or loss, the method comprising:

introducing into soft tissue in a patient, a hydrogel composition wherein the hydrogel composition comprises water and a crosslinked macromolecular matrix comprising

a hyaluronic acid component, and

a collagen component,

wherein the hyaluronic acid component is crosslinked to the collagen component by a crosslinking component, and

wherein the crosslinking component comprises a plurality of crosslink units, wherein at least a portion of the crosslink units comprise an ester bond or an amide bond.

23 . The method of claim 22 wherein the hydrogel composition has a weight ratio of the hyaluronic acid component to the collagen component of about 1 to about 7.

24 . The method of claim 22 wherein the hydrogel composition has a collagen concentration of about 3 mg/mL to about 12 mg/mL.

25 . The method of claim 24 wherein the hydrogel composition has a hyaluronic acid concentration of about 3 mg/mL to about 24 mg/mL.

26 . The method of claim 22 wherein the hydrogel composition has a collagen concentration of about 3 mg/mL and a hyaluronic acid concentration of about 3 mg/mL.

27 . The method of claim 22 wherein the hydrogel composition has a collagen concentration of about 3 mg/mL and a hyaluronic acid concentration of about 12 mg/mL.

28 . The method of claim 22 wherein the hydrogel composition has a collagen concentration of about 3 mg/mL and a hyaluronic acid concentration of about 16 mg/mL.

29 . The method of claim 22 wherein the hydrogel composition has a collagen concentration of about 3 mg/mL and a hyaluronic acid concentration of about 20 mg/mL.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 7, 2013
From: YU, XIAOJIE; TRAINA, CHRISTOPHER; KOKAI, LAUREN; VAN EPPS, DENNIS; MESSINA, DARIN
To: ALLERGAN, INC.
Reel/Frame 031564/0462 →